Pharmaceutical Approval Update.

Pharmaceutical Approval Update. P T. 2017 Oct;42(10):620-621 Authors: Kaufman MB Abstract L-glutamine oral powder (Endari) for reducing the acute complications of sickle cell disease; edaravone (Radicava) for the treatment of amyotrophic lateral sclerosis; and midostaurin (Rydapt) for the treatment of acute myeloid leukemia in combination with chemotherapy. PMID: 29018296 [PubMed]
Source: P and T - Category: Drugs & Pharmacology Tags: P T Source Type: research